Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections)

被引:50
作者
Ringheim, GE
Conant, K
机构
[1] Aventis Pharmaceut Inc, Immunol Platform, Bridgewater, NJ 08807 USA
[2] Johns Hopkins Univ Hosp, Sch Med, Dept Neurol, Baltimore, MD 21287 USA
关键词
neurodegeneration; Alzheimer's disease; Parkinson's disease; neuroimmune axis;
D O I
10.1016/j.jneuroim.2003.10.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The appearance of activated immune cells and the accumulation of inflammation-associated proteins are common phenomena associated with neurodegenerative diseases. These inflammatory components of central nervous system (CNS) diseases have most often been described in the context of an immune response to damage and cell loss already occurring in the affected brain area. There has, however, been a renewed interest in how the neuroimmune axis might itself be involved in the etiology of these neurodegenerative diseases, particularly in cases involving slow, chronic, progressive neuropathology. This review addresses immune activation in Alzheimer's, Parkinson's, and brain viral infections that may be causative of, rather than responsive to, the observed neuronal loss in these pathologies. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 83 条
[1]   Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice [J].
Abbas, N ;
Bednar, I ;
Mix, E ;
Marie, S ;
Paterson, D ;
Ljungberg, A ;
Morris, C ;
Winblad, B ;
Nordberg, A ;
Zhu, J .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 126 (1-2) :50-57
[2]   TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs [J].
Blasko, I ;
Marx, F ;
Steiner, E ;
Hartmann, T ;
Grubeck-Loebenstein, B .
FASEB JOURNAL, 1999, 13 (01) :63-68
[3]   Costimulatory effects of interferon-γ and interleukin-1β or tumor necrosis factor α on the synthesis of aβ1-40 and aβ1-42 by human astrocytes [J].
Blasko, I ;
Veerhuis, R ;
Stampfer-Kountchev, M ;
Saurwein-Teissl, M ;
Eikelenboom, P ;
Grubeck-Loebenstein, B .
NEUROBIOLOGY OF DISEASE, 2000, 7 (06) :682-689
[4]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[5]   DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS [J].
BREITNER, JCS ;
WELSH, KA ;
HELMS, MJ ;
GASKELL, PC ;
GAU, BA ;
ROSES, AD ;
PERICAKVANCE, MA ;
SAUNDERS, AM .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :523-530
[6]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554
[7]   Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo:: Implications for Alzheimer's disease [J].
Casamenti, F ;
Prosperi, C ;
Scali, C ;
Giovannelli, L ;
Colivicchi, MA ;
Faussone-Pellegrini, MS ;
Pepeu, G .
NEUROSCIENCE, 1999, 91 (03) :831-842
[8]   TRANSFORMING GROWTH-FACTOR-BETA PROTECTS HUMAN NEURONS AGAINST BETA-AMYLOID-INDUCED INJURY [J].
CHAO, CC ;
HU, SX ;
KRAVITZ, FH ;
TSANG, M ;
ANDERSON, WR ;
PETERSON, PK .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1994, 23 (2-3) :159-178
[9]   APOE genotype-specific differences in human and mouse macrophage nitric oxide production [J].
Colton, CA ;
Needham, LK ;
Brown, C ;
Cook, D ;
Rasheed, K ;
Burke, JR ;
Strittmatter, WJ ;
Schmechel, DE ;
Vitek, MP .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 147 (1-2) :62-67
[10]   APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomy [J].
DeGiorgio, LA ;
Shimizu, Y ;
Chun, HS ;
Cho, BP ;
Sugama, S ;
Joh, TH ;
Volpe, BT .
GLIA, 2002, 38 (02) :174-178